Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | phosphomevalonate kinase protein, putative | 0.0056 | 0.1145 | 0.1347 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0038 | 0.0733 | 0.0959 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0038 | 0.0733 | 0.0959 |
Trichomonas vaginalis | galactokinase, putative | 0.0177 | 0.4023 | 0.6014 |
Trypanosoma cruzi | fucose kinase, putative | 0.0076 | 0.162 | 0.1979 |
Echinococcus granulosus | diphosphomevalonate decarboxylase | 0.0056 | 0.1145 | 0.1498 |
Trichomonas vaginalis | galactokinase, putative | 0.0056 | 0.1145 | 0.1564 |
Trichomonas vaginalis | galactokinase, putative | 0.0076 | 0.162 | 0.2298 |
Trichomonas vaginalis | diphosphomevalonate decarboxylase, putative | 0.0056 | 0.1145 | 0.1564 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0038 | 0.0721 | 0.0782 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0013 | 0.0134 | 0.0175 |
Trypanosoma cruzi | galactokinase-like protein, putative | 0.0273 | 0.632 | 0.8238 |
Mycobacterium tuberculosis | Possible D-alpha-D-heptose-7-phosphate kinase HddA | 0.0131 | 0.2943 | 0.3741 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0285 | 0.6601 | 1 |
Echinococcus multilocularis | galactokinase | 0.0329 | 0.7643 | 1 |
Wolbachia endosymbiont of Brugia malayi | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0428 | 1 | 1 |
Echinococcus multilocularis | N acetylgalactosamine kinase | 0.0177 | 0.4023 | 0.5264 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0096 | 0.2102 | 0.2621 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0285 | 0.6601 | 1 |
Leishmania major | galactokinase-like protein | 0.0329 | 0.7643 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0057 | 0.118 | 0.2689 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0086 | 0.1873 | 0.2316 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0013 | 0.0134 | 0.0202 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0086 | 0.1873 | 0.2316 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0285 | 0.6601 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0038 | 0.0721 | 0.1033 |
Brugia malayi | galactokinase family protein | 0.0177 | 0.4023 | 0.607 |
Leishmania major | fucose kinase, putative | 0.0056 | 0.1145 | 0.1347 |
Leishmania major | fucose kinase, putative | 0.0056 | 0.1145 | 0.1347 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0038 | 0.0721 | 0.0871 |
Mycobacterium ulcerans | mevalonate kinase, Erg12 | 0.0131 | 0.2943 | 0.2848 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0044 | 0.0057 |
Schistosoma mansoni | mevalonate kinase | 0.0131 | 0.2943 | 0.4458 |
Echinococcus multilocularis | diphosphomevalonate decarboxylase | 0.0056 | 0.1145 | 0.1498 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0013 | 0.0134 | 0.0141 |
Giardia lamblia | Kinase, PLK | 0.0285 | 0.6601 | 1 |
Trypanosoma cruzi | phosphomevalonate kinase protein, putative | 0.0056 | 0.1145 | 0.1347 |
Trypanosoma brucei | polo-like protein kinase | 0.0285 | 0.6601 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0044 | 0.0057 |
Echinococcus granulosus | galactokinase | 0.0329 | 0.7643 | 1 |
Trichomonas vaginalis | galactokinase, putative | 0.0177 | 0.4023 | 0.6014 |
Trypanosoma brucei | phosphomevalonate kinase protein, putative | 0.0131 | 0.2943 | 0.4344 |
Plasmodium falciparum | glutathione reductase | 0.0038 | 0.0721 | 0.0871 |
Schistosoma mansoni | cpg binding protein | 0.0032 | 0.0579 | 0.0878 |
Trichomonas vaginalis | mevalonate kinase, putative | 0.0056 | 0.1145 | 0.1564 |
Trypanosoma cruzi | galactokinase, putative | 0.0273 | 0.632 | 0.8238 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0285 | 0.6601 | 1 |
Trypanosoma brucei | homoserine kinase | 0.0131 | 0.2943 | 0.4344 |
Toxoplasma gondii | GHMP kinase, N-terminal domain-containing protein | 0.0177 | 0.4023 | 1 |
Echinococcus multilocularis | cpg binding protein | 0.0032 | 0.0579 | 0.0758 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0096 | 0.2102 | 0.2621 |
Mycobacterium ulcerans | homoserine kinase | 0.0131 | 0.2943 | 0.2848 |
Plasmodium falciparum | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, putative | 0.0297 | 0.6879 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0096 | 0.2102 | 0.108 |
Onchocerca volvulus | 0.0056 | 0.1145 | 0.1001 | |
Echinococcus granulosus | Mevalonate galactokinase | 0.0131 | 0.2943 | 0.3851 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0056 | 0.1145 | 0.1564 |
Plasmodium falciparum | thioredoxin reductase | 0.0038 | 0.0721 | 0.0871 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.2943 | 0.4422 |
Schistosoma mansoni | cpg binding protein | 0.0032 | 0.0579 | 0.0878 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0141 | 0.3178 | 0.4707 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0096 | 0.2102 | 0.2621 |
Trypanosoma brucei | mevalonate-diphosphate decarboxylase | 0.0056 | 0.1145 | 0.1564 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0086 | 0.1873 | 0.2316 |
Trypanosoma cruzi | homoserine kinase | 0.0131 | 0.2943 | 0.3741 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0285 | 0.6601 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0222 | 0.5096 | 0.503 |
Chlamydia trachomatis | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0352 | 0.8202 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0285 | 0.6601 | 1 |
Echinococcus granulosus | N acetylgalactosamine kinase | 0.0177 | 0.4023 | 0.5264 |
Schistosoma mansoni | kinase | 0.0145 | 0.3267 | 0.495 |
Trypanosoma cruzi | mevalonate-diphosphate decarboxylase, putative | 0.0056 | 0.1145 | 0.1347 |
Trypanosoma cruzi | fucose kinase, putative | 0.0076 | 0.162 | 0.1979 |
Brugia malayi | glutathione reductase | 0.0038 | 0.0721 | 0.1037 |
Loa Loa (eye worm) | galactokinase | 0.0177 | 0.4023 | 0.6068 |
Echinococcus granulosus | cpg binding protein | 0.0032 | 0.0579 | 0.0758 |
Mycobacterium ulcerans | galactokinase | 0.0329 | 0.7643 | 0.7611 |
Mycobacterium ulcerans | phosphomevalonate kinase | 0.0131 | 0.2943 | 0.2848 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0285 | 0.6601 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0013 | 0.0134 | 0.0175 |
Leishmania major | homoserine kinase, putative | 0.0131 | 0.2943 | 0.3741 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.1145 | 0.168 |
Brugia malayi | mevalonate kinase family protein | 0.0131 | 0.2943 | 0.4424 |
Schistosoma mansoni | galactokinase | 0.0177 | 0.4023 | 0.6094 |
Echinococcus multilocularis | Mevalonate galactokinase | 0.0131 | 0.2943 | 0.3851 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0285 | 0.6601 | 0.8613 |
Giardia lamblia | Mevalonate kinase | 0.0131 | 0.2943 | 0.4344 |
Brugia malayi | diphosphomevalonate decarboxylase family protein | 0.0056 | 0.1145 | 0.1683 |
Trypanosoma cruzi | galactokinase, putative | 0.0329 | 0.7643 | 1 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0086 | 0.1873 | 0.0822 |
Schistosoma mansoni | diphosphomevalonate decarboxylase | 0.0056 | 0.1145 | 0.1735 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0285 | 0.6601 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0038 | 0.0721 | 0.0908 |
Entamoeba histolytica | galactokinase, putative | 0.0329 | 0.7643 | 1 |
Trypanosoma cruzi | mevalonate kinase, putative | 0.0131 | 0.2943 | 0.3741 |
Trypanosoma cruzi | homoserine kinase | 0.0131 | 0.2943 | 0.3741 |
Plasmodium vivax | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, putative | 0.0297 | 0.6879 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0285 | 0.6601 | 0.8637 |
Leishmania major | mevalonate-diphosphate decarboxylase, putative | 0.0056 | 0.1145 | 0.1347 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.001 | 0.0051 | 0.0015 |
Brugia malayi | CXXC zinc finger family protein | 0.003 | 0.0539 | 0.0759 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0285 | 0.6601 | 0.8613 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0086 | 0.1873 | 0.2316 |
Toxoplasma gondii | GHMP kinase, putative | 0.0131 | 0.2943 | 0.7224 |
Giardia lamblia | Diphosphomevalonate decarboxylase | 0.0056 | 0.1145 | 0.1564 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0086 | 0.1873 | 0.2316 |
Trichomonas vaginalis | galactokinase, putative | 0.0177 | 0.4023 | 0.6014 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0285 | 0.6601 | 0.8613 |
Schistosoma mansoni | hypothetical protein | 0.0169 | 0.3849 | 0.5831 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0064 | 0.1342 | 0.2033 |
Trichomonas vaginalis | galactokinase, putative | 0.0177 | 0.4023 | 0.6014 |
Mycobacterium tuberculosis | Probable homoserine kinase ThrB | 0.0056 | 0.1145 | 0.1347 |
Brugia malayi | Thioredoxin reductase | 0.0038 | 0.0721 | 0.1037 |
Toxoplasma gondii | thioredoxin reductase | 0.0038 | 0.0721 | 0.151 |
Mycobacterium ulcerans | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0428 | 1 | 1 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0285 | 0.6601 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0285 | 0.6601 | 0.8637 |
Mycobacterium tuberculosis | Probable galactokinase GalK (galactose kinase) | 0.0329 | 0.7643 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0285 | 0.6601 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0038 | 0.0721 | 0.0871 |
Schistosoma mansoni | hypothetical protein | 0.0169 | 0.3849 | 0.5831 |
Leishmania major | trypanothione reductase | 0.0038 | 0.0721 | 0.0782 |
Leishmania major | phosphomevalonate kinase protein, putative | 0.0131 | 0.2943 | 0.3741 |
Loa Loa (eye worm) | glutathione reductase | 0.0038 | 0.0721 | 0.1033 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.003 | 0.0539 | 0.0755 |
Mycobacterium ulcerans | diphosphomevalonate decarboxylase | 0.0056 | 0.1145 | 0.1025 |
Trypanosoma brucei | mevalonate kinase, putative | 0.0131 | 0.2943 | 0.4344 |
Echinococcus granulosus | geminin | 0.0169 | 0.3849 | 0.5036 |
Treponema pallidum | galactokinase | 0.0273 | 0.632 | 0.627 |
Mycobacterium tuberculosis | Probable 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase IspE (CMK) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase) | 0.0297 | 0.6879 | 0.8982 |
Trypanosoma cruzi | mevalonate-diphosphate decarboxylase, putative | 0.0056 | 0.1145 | 0.1347 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0539 | 0.0816 |
Echinococcus multilocularis | geminin | 0.0169 | 0.3849 | 0.5036 |
Leishmania major | mevalonate kinase, putative | 0.0131 | 0.2943 | 0.3741 |
Mycobacterium tuberculosis | Probable reductase | 0.0086 | 0.1873 | 0.2316 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0038 | 0.0721 | 0.0782 |
Treponema pallidum | hypothetical protein | 0.0428 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0141 | 0.3178 | 0.4707 |
Trypanosoma cruzi | galactokinase, putative | 0.0329 | 0.7643 | 1 |
Trypanosoma brucei | mevalonate diphosphate decarboxylase | 0.0056 | 0.1145 | 0.1564 |
Trypanosoma brucei | galactokinase-like protein, putative | 0.0208 | 0.4765 | 0.7161 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0285 | 0.6601 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.001 | 0.0051 | 0.0015 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.